More Good News for Self-Administered Nasal Spray in PSVT More Good News for Self-Administered Nasal Spray in PSVT

The safety and tolerability of etripamil, an investigational nasal spray for paroxysmal supraventricular tachycardia (PSVT), are maintained in new data from the NODE-302 extension study.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news
More News: Cardiology | Heart | Study